These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 10235192

  • 1. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N, Cutler A.
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [Abstract] [Full Text] [Related]

  • 2. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ, O'Connell S, Schnell T, Chejfec G, Seidel J, Sonnenberg A.
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [Abstract] [Full Text] [Related]

  • 3. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH, Yeung CK, Lee KH.
    Aliment Pharmacol Ther; 2006 Jul 01; 24(1):81-6. PubMed ID: 16803605
    [Abstract] [Full Text] [Related]

  • 4. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L, Estrada R, Trujillo M, Emami S.
    Am J Gastroenterol; 1997 Dec 01; 92(12):2213-5. PubMed ID: 9399755
    [Abstract] [Full Text] [Related]

  • 5. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
    Cammarota G, Cannizzaro O, Cianci R, Gasbarrini A, Pirozzi G, Gasbarrini G.
    Hepatogastroenterology; 2000 Dec 01; 47(34):1176-9. PubMed ID: 11020908
    [Abstract] [Full Text] [Related]

  • 6. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA, Haeck PW, Otten MH, Mulder CJ.
    Am J Gastroenterol; 1998 Jul 01; 93(7):1101-7. PubMed ID: 9672338
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J, Halle ZB, Strinić D, Kućisec N, Jandrić D, Bevanda M, Tomić M, Bilić A.
    Wien Klin Wochenschr; 2002 Jun 28; 114(12):448-53. PubMed ID: 12422579
    [Abstract] [Full Text] [Related]

  • 9. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ, Thijs JC, van Zwet AA, Kooy A, Kleibeuker JH.
    Am J Gastroenterol; 1998 Aug 28; 93(8):1228-31. PubMed ID: 9707042
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
    Akyildiz M, Akay S, Musoglu A, Tuncyurek M, Aydin A.
    Eur J Intern Med; 2009 Jan 28; 20(1):53-7. PubMed ID: 19237093
    [Abstract] [Full Text] [Related]

  • 11. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD, Wurzer H, Marcelino M, Jahnsen J, Lotay N, Roberts PM.
    Am J Gastroenterol; 1998 Mar 28; 93(3):380-5. PubMed ID: 9517644
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
    Tursi A, Brandimarte G, Giorgetti G, Modeo ME, Gigliobianco A.
    Hepatogastroenterology; 2002 Mar 28; 49(46):1006-9. PubMed ID: 12143188
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Thong-Ngam D, Tangkijvanich P, Treeprasertsuk S, Wisedopas N, Kullavanijaya P.
    J Med Assoc Thai; 2002 Oct 28; 85(10):1054-9. PubMed ID: 12501895
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
    Laine L, Suchower L, Frantz J, Connors A, Neil G.
    Am J Gastroenterol; 1998 Nov 28; 93(11):2106-12. PubMed ID: 9820381
    [Abstract] [Full Text] [Related]

  • 16. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M, Székely E, Illyés G, Széles I.
    Orv Hetil; 2000 Jul 30; 141(31):1711-4. PubMed ID: 10976194
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori.
    Smoot DT, Hinds T, Ashktorab H, Jagtap J, Kim KS, Scott VF.
    Am J Gastroenterol; 1999 Apr 30; 94(4):955-8. PubMed ID: 10201463
    [Abstract] [Full Text] [Related]

  • 18. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q, Liang X, Zheng Q, Liu W, Xiao S, Gu W, Lu H.
    Helicobacter; 2010 Jun 30; 15(3):233-8. PubMed ID: 20557366
    [Abstract] [Full Text] [Related]

  • 19. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN, Sung JJ, Yuen NW, Li TH, Ng PW, Lai WM, Lui YH, Lam KN, Choi CH, Leung EM.
    Am J Gastroenterol; 1999 Mar 30; 94(3):721-4. PubMed ID: 10086657
    [Abstract] [Full Text] [Related]

  • 20. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
    Gisbert JP, Fuentes J, Carpio D, Tito L, Guardiola J, Tomas A, Olivares D, Calvet X.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1249-53. PubMed ID: 15882246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.